Citations (93)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
PH Chandrasekar. (2008) Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate. Therapeutics and Clinical Risk Management 4:6, pages 1285-1294.
Read now
Read now
Gillian Barratt & Stéphane Bretagne. (2007) Optimizing efficacy of Amphotericin B through nanomodification. International Journal of Nanomedicine 2:3, pages 301-313.
Read now
Read now
J.-U. Junghanns, I. Buttle, R.H. Müller, I.B. Araújo, A.K.A. Silva, E.S.T. Egito & B.P.G.L. Damasceno. (2007) SolEmuls® Technology: A Way to Overcome the Drawback of Parenteral Administration of Insoluble Drugs. Pharmaceutical Development and Technology 12:5, pages 437-445.
Read now
Read now
Suresh P Vyas & Swati Gupta. (2006) Optimizing efficacy of amphotericin B through nanomodification. International Journal of Nanomedicine 1:4, pages 417-432.
Read now
Read now
Rodrigo Martino. (2004) Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature. Current Medical Research and Opinion 20:4, pages 485-504.
Read now
Read now
John H Rex & Sevtap Arikan. (2002) New agents for the treatment of systemic fungal infections – current status. Expert Opinion on Emerging Drugs 7:1, pages 3-32.
Read now
Read now
A. Trouet. (2002) THE AMPHOTERICIN B LIPID COMPLEX OR ABELCET: ITS BELGIAN CONNECTION, ITS MODE OF ACTION AND SPECIFICITY : A REVIEW. Acta Clinica Belgica 57:2, pages 53-57.
Read now
Read now
B. Ma, J. F. Seymour, H. Januszewicz & M.A Slavin. (2001) Cure of Pulmonary Rhizomucor Pusillus Infection in a Patient with Hairy-Cell Leukemia: Role of Liposomal Amphotericin B and GM-CSF. Leukemia & Lymphoma 42:6, pages 1393-1399.
Read now
Read now
Leila Zarif, John R. Graybill, David Perlin & Raphael J. Mannino. (2000) Cochleates: New Lipid-Based Drug Delivery System. Journal of Liposome Research 10:4, pages 523-538.
Read now
Read now
Theodore F. Taraschi & Joseph M. Beggs. (2000) Letters. Journal of Liposome Research 10:1, pages 96-98.
Read now
Read now
John W. Hiemenz & Thomas J. Walsh. (1998) Lipid Formulations of Amphotericin. Journal of Liposome Research 8:4, pages 443-467.
Read now
Read now
Yechezkel Barenholz & Rivka Cohen. (1995) Rational design of amphiphile-based drug carriers and sterically stabilized carriers. Journal of Liposome Research 5:4, pages 905-932.
Read now
Read now
A. S. Janoff. (1995) Liposomes, drugs and industry. Journal of Liposome Research 5:4, pages 747-749.
Read now
Read now
Francis C. Szoka & Mary Tang. (1993) Amphotericin B Formulated in Liposomes and Lipid Based Systems: A Review. Journal of Liposome Research 3:3, pages 363-375.
Read now
Read now
Articles from other publishers (79)
Tahir Mehmood, Fareeha Nadeem, Muhammad Bilal, Bisma Meer, Kushif Meer & Hajra Ashraf. 2023. Valorization of Biomass to Bioproducts. Valorization of Biomass to Bioproducts
87
111
.
Shobha Kumari, Vikash Kumar, Ritesh Kumar Tiwari, Vidyanand Ravidas, Krishna Pandey & Ashish Kumar. (2022) Amphotericin B: A drug of choice for Visceral Leishmaniasis. Acta Tropica 235, pages 106661.
Crossref
Crossref
Tammy Haro-Reyes, Lucero Díaz-Peralta, Arturo Galván-Hernández, Anahi Rodríguez-López, Lourdes Rodríguez-Fragoso & Iván Ortega-Blake. (2022) Polyene Antibiotics Physical Chemistry and Their Effect on Lipid Membranes; Impacting Biological Processes and Medical Applications. Membranes 12:7, pages 681.
Crossref
Crossref
Dan Ye, Liyan Shen, Ying Sun, Di Zhang, Xiao Tan, Panpan Jing, Min Zhang & Qingping Tian. (2021) Formulation and evaluation of a α-linolenic acid and vitamin E succinate microemulsion with low surfactant content and free of co-surfactant for use as a nutritional supplement. Food Chemistry 364, pages 130433.
Crossref
Crossref
Peter Hoogevest, Harry Tiemessen, Josbert M. Metselaar, Simon Drescher & Alfred Fahr. (2021) The Use of Phospholipids to Make Pharmaceutical Form Line Extensions. European Journal of Lipid Science and Technology 123:4, pages 2000297.
Crossref
Crossref
Ada Leung, Carolyn Amador, Lin Chuan Wang, Urmi Mody & Marcel Bally. (2019) What Drives Innovation: The Canadian Touch on Liposomal Therapeutics. Pharmaceutics 11:3, pages 124.
Crossref
Crossref
B. Bikbov, N. Perico, M. Abbate & G. Remuzzi. 2018. Comprehensive Toxicology. Comprehensive Toxicology
189
206
.
J.C. Debouzy, L. Mehenni, D. Crouzier, M. Lahiani-Skiba, G. Nugue & M. Skiba. (2017) NMR and ESR study of amphotericin B interactions with various binary phosphatidylcholine/phosphatidylglycerol membranes. International Journal of Pharmaceutics 521:1-2, pages 384-394.
Crossref
Crossref
Upendra Bulbake, Sindhu Doppalapudi, Nagavendra Kommineni & Wahid Khan. (2017) Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9:4, pages 12.
Crossref
Crossref
Dipu Sathyapalan, Sabarish Balachandran, Anil Kumar, Bindu Mangalath Rajamma, Ashok Pillai & Vidya P. Menon. (2016) Long term outcome of medical and surgical co-management of craniospinal aspergillosis in an immunocompromised patient. Medical Mycology Case Reports 14, pages 33-37.
Crossref
Crossref
Gustavo Julio Borges Arruda, Gustavo Rossanezi, Maria Virginia Scarpa, Erivaldo Socrates Tabosa do Egito & Anselmo Gomes de Oliveira. (2016) ESTRATÉGIAS TECNOLÓGICAS PARA FORMULAÇÕES DE ANFOTERICINA B EM SISTEMAS LIPÍDICOS DISPONÍVEIS NO MERCADO FARMACÊUTICO E OUTROS PROMISSORES SISTEMAS DE ADMINISTRAÇÃO. Infarma - Ciências Farmacêuticas 28:2, pages 59-67.
Crossref
Crossref
Rima Moghnieh, Nabila El-Rajab, Dania Issam Abdallah, Ismail Fawaz, Anas Mugharbil, Tamima Jisr & Ahmad Ibrahim. (2016) Retrospective Analysis on the Use of Amphotericin B Lipid Complex in Neutropenic Cancer Patients with Suspected Fungal Infections in Lebanon, a Single Center Experience and Review of International Guidelines. Frontiers in Medicine 2.
Crossref
Crossref
F. FogliaS. E. RogersJ. R. P. WebsterF. A. Akeroyd, K. F. Gascoyne, M. J. LawrenceD. J. Barlow. (2015) Neutron Scattering Studies of the Effects of Formulating Amphotericin B with Cholesteryl Sulfate on the Drug’s Interactions with Phospholipid and Phospholipid–Sterol Membranes. Langmuir 31:29, pages 8042-8051.
Crossref
Crossref
Chris Stockmann, Jonathan E. Constance, Jessica K. Roberts, Jared Olson, Elizabeth H. Doby, Krow Ampofo, Justin Stiers, Michael G. Spigarelli & Catherine M. T. Sherwin. (2014) Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications. Clinical Pharmacokinetics 53:5, pages 429-454.
Crossref
Crossref
B. Bikbov, N. Perico, M. Abbate & G. Remuzzi. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Abeer H. A. Mohamed-Ahmed, Karin Seifert, Vanessa Yardley, Hollie Burrell-Saward, Stephen Brocchini & Simon L. Croft. (2013) Antileishmanial Activity, Uptake, and Biodistribution of an Amphotericin B and Poly(α-Glutamic Acid) Complex. Antimicrobial Agents and Chemotherapy 57:10, pages 4608-4614.
Crossref
Crossref
Philippe M. Loiseau & Gillian Barratt. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
321
350
.
Daniel S. Foy & Lauren A. Trepanier. (2010) Antifungal Treatment of Small Animal Veterinary Patients. Veterinary Clinics of North America: Small Animal Practice 40:6, pages 1171-1188.
Crossref
Crossref
B. Bikbov, N. Perico, M. Abbate & G. Remuzzi. 2010. Comprehensive Toxicology. Comprehensive Toxicology
245
261
.
Vassilios Fanos, Marco Zaffanello, Laura Cuzzolin & Luigi Cataldi. 2010. Combating Fungal Infections. Combating Fungal Infections
109
124
.
P. Roussos, R. E. Lewis & D. P. Kontoyiannis. (2009) Azoles and antidepressants: a mini-review of the tolerability of co-administration. Mycoses 52:5, pages 433-439.
Crossref
Crossref
Bijoy P. Mathew & Mahendra Nath. (2009) Recent Approaches to Antifungal Therapy for Invasive Mycoses. ChemMedChem 4:3, pages 310-323.
Crossref
Crossref
J.P. Adler-Moore & R.T. Proffitt. (2008) Amphotericin B lipid preparations: what are the differences?. Clinical Microbiology and Infection 14, pages 25-36.
Crossref
Crossref
Miloš Sedlák, Pavel Drabina, Eliška Bílková, Petr Šimůnek & Vladimír Buchta. (2008) New targeting system for antimycotic drugs: β-Glucosidase sensitive Amphotericin B–star poly(ethylene glycol) conjugate. Bioorganic & Medicinal Chemistry Letters 18:9, pages 2952-2956.
Crossref
Crossref
Miloš Sedlák, Martin Pravda, Frantisek Staud, Lenka Kubicová, Kateřina Týčová & Karel Ventura. (2007) Synthesis of pH-sensitive amphotericin B–poly(ethylene glycol) conjugates and study of their controlled release in vitro. Bioorganic & Medicinal Chemistry 15:12, pages 4069-4076.
Crossref
Crossref
Miloš Sedlák, Martin Pravda, Lenka Kubicová, Petra Mikulčíková & Karel Ventura. (2007) Synthesis and characterisation of a new pH-sensitive amphotericin B—poly(ethylene glycol)-b-poly(l-lysine) conjugate. Bioorganic & Medicinal Chemistry Letters 17:9, pages 2554-2557.
Crossref
Crossref
S. Dean Allison. (2007) Liposomal Drug Delivery. Journal of Infusion Nursing 30:2, pages 89-95.
Crossref
Crossref
Georg Maschmeyer, Antje Haas & Oliver A Cornely. (2007) Invasive Aspergillosis. Drugs 67:11, pages 1567-1601.
Crossref
Crossref
Malika Larabi, Philippe Legrand & Gillian Barratt. 2006. Liposome Technology, Volume II. Liposome Technology, Volume II
93
110
.
Jon A. Olson, Jill P. Adler-Moore, Julie Schwartz, Gerard M. Jensen & Richard T. Proffitt. (2006) Comparative Efficacies, Toxicities, and Tissue Concentrations of Amphotericin B Lipid Formulations in a Murine Pulmonary Aspergillosis Model. Antimicrobial Agents and Chemotherapy 50:6, pages 2122-2131.
Crossref
Crossref
Yutaka Yamamoto. (2006) "Novel applications of DDS on infectious diseases and future prospect" Application of DDS to fungal infection diseases. Drug Delivery System 21:5, pages 529-535.
Crossref
Crossref
Leila Zarif. 2005. Liposomes. Liposomes
314
329
.
J.-M. Aguado, C. Lumbreras & D. González-Vidal. (2004) Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain. Clinical Microbiology and Infection 10:9, pages 785-790.
Crossref
Crossref
Begoña Brime, Gloria Molero, Paloma Frutos & Gloria Frutos. (2004) Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil–water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans. European Journal of Pharmaceutical Sciences 22:5, pages 451-458.
Crossref
Crossref
Malika Larabi, Annette Gulik, Jean-Paul Dedieu, Philippe Legrand, Gillian Barratt & Monique Cheron. (2004) New lipid formulation of amphotericin B: spectral and microscopic analysis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1664:2, pages 172-181.
Crossref
Crossref
Ran D. Goldman & Gideon Koren. (2004) Amphotericin B Nephrotoxicity in Children. Journal of Pediatric Hematology/Oncology 26:7, pages 421-426.
Crossref
Crossref
J. P. Adler-Moore & R. T. Proffitt. 2004. Human Fungal Pathogens. Human Fungal Pathogens
339
362
.
Amy M. Grooters & Joseph Taboada. (2003) Update on antifungal therapy. Veterinary Clinics of North America: Small Animal Practice 33:4, pages 749-758.
Crossref
Crossref
D.P. Kontoyiannis, E. Mantadakis & G. Samonis. (2003) Systemic mycoses in the immunocompromised host: an update in antifungal therapy. Journal of Hospital Infection 53:4, pages 243-258.
Crossref
Crossref
E.Sócrates T. Egito, Ivonete B. Araújo, Bolivar P.G.L. Damasceno & James C. Price. (2002) Amphotericin B/Emulsion Admixture Interactions: An Approach Concerning the Reduction of Amphotericin B Toxicity. Journal of Pharmaceutical Sciences 91:11, pages 2354-2366.
Crossref
Crossref
Ignacio Segarra, Diane A. Movshin & Leila Zarif. (2002) Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid‐based delivery system. Journal of Pharmaceutical Sciences 91:8, pages 1827-1837.
Crossref
Crossref
Leila Zarif. (2002) Elongated supramolecular assemblies in drug delivery. Journal of Controlled Release 81:1-2, pages 7-23.
Crossref
Crossref
Begoña Brime, Marco A. Moreno, Gloria Frutos, Ma.Paloma Ballesteros & Paloma Frutos. (2002) Amphotericin B in Oil–Water Lecithin-Based Microemulsions: Formulation and Toxicity Evaluation. Journal of Pharmaceutical Sciences 91:4, pages 1178-1185.
Crossref
Crossref
Miloš Sedlák, Vladimı́r Buchta, Lenka Kubicová, Petr Šimůnek, Michal Holčapek & Pavla Kašparová. (2001) Synthesis and characterisation of a new amphotericin b–methoxypoly(ethylene glycol) conjugate. Bioorganic & Medicinal Chemistry Letters 11:21, pages 2833-2835.
Crossref
Crossref
Rod E Quilitz, Alana D Arnold, Gabriel R Briones, Suzanne P Dix, Cindy Ippoliti, LeAnne D Kennedy, Jeanne L Lucich, Jayesh Mehta, Byron G Peters & David S Tice. (2016) Practice Guidelines for Lipid-Based Amphotericin B in Stem Cell Transplant Recipients. Annals of Pharmacotherapy 35:2, pages 206-216.
Crossref
Crossref
J. R. Wingard, M. H. White, E. Anaissie, J. Raffalli, J. Goodman & A. Arrieta. (2000) A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia. Clinical Infectious Diseases 31:5, pages 1155-1163.
Crossref
Crossref
David Goldblum, Beatrice E. Frueh, Stefan Zimmerli & Matthias Böhnke. (2000) Treatment of Postkeratitis Fusarium Endophthalmitis with Amphotericin B Lipid Complex. Cornea 19:6, pages 853-856.
Crossref
Crossref
Adedayo AdedoyinChristine E. Swenson, Lois E. Bolcsak, Andrzej Hellmann, Danuta Radowska, Gary Horwith, Andrew S. Janoff & Robert A. Branch. (2000) A Pharmacokinetic Study of Amphotericin B Lipid Complex Injection (Abelcet) in Patients with Definite or Probable Systemic Fungal Infections. Antimicrobial Agents and Chemotherapy 44:10, pages 2900-2902.
Crossref
Crossref
Richard A. Zager. (2000) Polyene antibiotics: Relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content. American Journal of Kidney Diseases 36:2, pages 238-249.
Crossref
Crossref
Peter Linden, Penny Williams & Kevin M Chan. (2003) Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections. Clinical Transplantation 14:4, pages 329-339.
Crossref
Crossref
Idit Matot & Reuven Pizov. (2000) Pulmonary extraction and accumulation of lipid formulations of amphotericin B. Critical Care Medicine 28:7, pages 2528-2532.
Crossref
Crossref
Mahmoud A. Ghannoum. (2000) Potential Role of Phospholipases in Virulence and Fungal Pathogenesis. Clinical Microbiology Reviews 13:1, pages 122-143.
Crossref
Crossref
Calum J Drummond & Celesta Fong. (1999) Surfactant self-assembly objects as novel drug delivery vehicles. Current Opinion in Colloid & Interface Science 4:6, pages 449-456.
Crossref
Crossref
Peter Linden, Lily Lee & Thomas J. Walsh. (2012) Retrospective Analysis of the Dosage of Amphotericin B Lipid Complex for the Treatment of Invasive Fungal Infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19:11, pages 1261-1268.
Crossref
Crossref
Alan Murphy & Kevin Kavanagh. (1999) Emergence of Saccharomyces cerevisiae as a human pathogen. Enzyme and Microbial Technology 25:7, pages 551-557.
Crossref
Crossref
THOMAS J. WALSH, NITA L. SEIBEL, CAROLA ARNDT, RICHARD E. HARRIS, MARK J. DINUBILE, ANNETTE REBOLI, JOHN HIEMENZ & STEPHEN J. CHANOCK. (1999) Amphotericin B lipid complex in pediatric patients with invasive fungal infections. The Pediatric Infectious Disease Journal 18:8, pages 702-708.
Crossref
Crossref
Jayesh Mehta. (2001) Lipid preparations of amphotericin for the treatment of fungal infections. British Journal of Haematology 105:3, pages 845-847.
Crossref
Crossref
Ihor Bekersky, Robert M Fielding, Donald Buell & Ira Lawrence. (1999) Lipid-based amphotericin B formulations: from animals to man. Pharmaceutical Science & Technology Today 2:6, pages 230-236.
Crossref
Crossref
Douglas Slain. (2012) Lipid‐Based Amphotericin B for the Treatment of Fungal Infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19:3, pages 306-323.
Crossref
Crossref
Clark, Mckendrick, Tansey, Franklin & Chopra. (2002) A comparative analysis of lipid‐complexed and liposomal amphotericin B preparations in haematological oncology. British Journal of Haematology 103:1, pages 198-204.
Crossref
Crossref
Elizabeth M. Johnson, Joshua O. Ojwang, Adrien Szekely, Thomas L. Wallace & David W. Warnock. (1998) Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations. Antimicrobial Agents and Chemotherapy 42:6, pages 1412-1416.
Crossref
Crossref
Christine E. Swenson, Walter R. Perkins, Patricia Roberts, Imran Ahmad, Rachel Stevens, David A. Stevens & Andrew S. Janoff. (1998) In Vitro and In Vivo Antifungal Activity of Amphotericin B Lipid Complex: Are Phospholipases Important?. Antimicrobial Agents and Chemotherapy 42:4, pages 767-771.
Crossref
Crossref
Gert Storm & Daan J.A Crommelin. (1998) Liposomes: quo vadis?. Pharmaceutical Science & Technology Today 1:1, pages 19-31.
Crossref
Crossref
Andreas H. Groll, Stephen C. Piscitelli & Thomas J. Walsh. 1998.
343
500
.
CHRISTINE E. SWENSON, JEFFREY FREITAG & ANDREW S. JANOFF. 1998. Medical Applications of Liposomes. Medical Applications of Liposomes
689
702
.
Shigeru Kohno, Kazunori Tomono & Shigefumi Maesaki. (1998) Drug Delivery Systems for Infection: Liposome-Incorporating Antimicrobial Drugs. Journal of Infection and Chemotherapy 4:4, pages 159-173.
Crossref
Crossref
F Gaboriau, M Chéron, C Petit & J Bolard. (1997) Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index. Antimicrobial Agents and Chemotherapy 41:11, pages 2345-2351.
Crossref
Crossref
Robert P Rapp, Paul O Gubbins & Martin E Evans. (2016) Amphotericin B Lipid Complex. Annals of Pharmacotherapy 31:10, pages 1174-1186.
Crossref
Crossref
H. Merhav & L. Mieles. (1997) Amphotericin B lipid complex in the treatment of invasive fungal infections in liver transplant patients. Transplantation Proceedings 29:6, pages 2670-2674.
Crossref
Crossref
R BhamraA Sa'adL E BolcsakA S JanoffC E Swenson. (1997) Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats. Antimicrobial Agents and Chemotherapy 41:5, pages 886-892.
Crossref
Crossref
François Gaboriau, Monique Chéron, Liliane Leroy & Jacques Bolard. (1997) Physico-chemical properties of the heat-induced ‘superaggregates’ of amphotericin B. Biophysical Chemistry 66:1, pages 1-12.
Crossref
Crossref
V HeinemannB KähnyU JehnD MühlbayerA DebusK WachholzD BosseH J KolbW Wilmanns. (1997) Serum pharmacology of amphotericin B applied in lipid emulsions. Antimicrobial Agents and Chemotherapy 41:4, pages 728-732.
Crossref
Crossref
Anya M. Hillery. (1997) Supramolecular lipidic drug delivery systems: From laboratory to clinic A review of the recently introduced commercial liposomal and lipid-based formulations of amphotericin B. Advanced Drug Delivery Reviews 24:2-3, pages 345-363.
Crossref
Crossref
Jayesh Mehta. (1997) Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?. Leukemia Research 21:3, pages 183-188.
Crossref
Crossref
Ayelet M. Samuni, Yechezkel Barenholz, Daan J.A. Crommelin & Nicolaas J. Zuidam. (1997) γ-Irradiation Damage to Liposomes Differing in Composition and Their Protection by Nitroxides. Free Radical Biology and Medicine 23:7, pages 972-979.
Crossref
Crossref
G. Storm & E. Etten. (1997) Biopharmaceutical aspects of lipid formulations of amphotericin B. European Journal of Clinical Microbiology & Infectious Diseases 16:1, pages 64-73.
Crossref
Crossref
J BrajtburgJ Bolard. (1996) Carrier effects on biological activity of amphotericin B. Clinical Microbiology Reviews 9:4, pages 512-531.
Crossref
Crossref
J. Lister. (2009) Amphotericin B Lipid Complex (Abelcet®) in the treatment of invasive mycoses: the North American experience. European Journal of Haematology 56:S57, pages 18-23.
Crossref
Crossref
Brian D. Wolf & Scott C. Hartsel. (1995) Osmotic stress sensitizes sterol-free phospholipid bilayers to the action of Amphotericin B. Biochimica et Biophysica Acta (BBA) - Biomembranes 1238:2, pages 156-162.
Crossref
Crossref